Davion Healthcare Plc Opens New Miami Office for U.S. Operations
Davion Healthcare Plc, an Irish-registered public company specializing in non-invasive medical technologies, today announced the opening of a new office in Miami, Florida. The office will serve as the headquarters of Davion Healthcare Corporation, overseeing all U.S. business operations.
The Miami office strengthens Davion’s U.S. presence as the company prepares to launch its flagship product, BreastCheck™, along with its pipeline of non-invasive screening tools. It will provide a dedicated base for regulatory, commercial, and partner engagement activities in one of the company’s key growth markets.
BreastCheck™, is an FDA-registered, non-invasive at-home breast health screening test that enables women to proactively and conveniently monitor breast tissue temperature at home, delivering instant results through a companion mobile app or web portal that can indicate potential abnormalities.
About Davion
Davion Healthcare Plc (www.davionhealthcare.com) is a medical technology company developing non-invasive home tests for early-stage identification of various medical anomalies including cancer.
Its lead product, BreastCheck™, is an FDA-registered at-home breast health screening test that uses a thermosensitive patch and companion mobile app to help detect potential anomalies early and without the need for a clinical visit.
Davion operates a capital-light, licensing-led model, designing and registering proprietary monitoring tools, while partnering with third parties for manufacturing and distribution.